» Authors » Andrea Bianconi

Andrea Bianconi

Explore the profile of Andrea Bianconi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 172
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Caneva S, Hamedani M, Pesaresi A, Mori L, Marzi A, Pellegrino L, et al.
Eur J Neurol . 2025 Mar; 32(3):e16567. PMID: 40087849
Background: Idiopathic normal pressure hydrocephalus (iNPH) is a multifactorial progressive disease affecting cognition, gait, and urinary continence, potentially reversible, or at least improvable, by a prompt surgical intervention. Given its...
2.
Altieri R, Bianconi A, Caneva S, Cirillo G, Cofano F, Corvino S, et al.
Acta Neurochir (Wien) . 2025 Mar; 167(1):71. PMID: 40072663
Background: Inferior Fronto-Occipital Fascicle (IFOF) is a multitasking connection bundle essential for communication and high level mentalization. The aim of the present study was to quantitatively assess its radiological-anatomical-morphometric modifications...
3.
Morello A, Rizzo F, Gatto A, Panico F, Bianconi A, Chiari G, et al.
Curr Oncol . 2025 Feb; 32(2). PMID: 39996898
Gliomas within the insular region represent one of the most challenging problems in neurosurgical oncology. There are two main surgical approaches to address the complex vascular network and functional areas...
4.
Minardi M, Bianconi A, Mesin L, Salvati L, Griva F, Narducci A
J Clin Med . 2025 Jan; 14(2). PMID: 39860581
Aneurysmal subarachnoid hemorrhage (aSAH) carries significant mortality and disability rates, with rebleeding posing a grave risk, particularly in anterior communicating artery (AcoA) aneurysms. This retrospective study aims to analyze preoperative...
5.
6.
Panico F, Bianconi A, Bertero L, Palmiero R, Zeppa P, Ricci A, et al.
Neurol Sci . 2024 Dec; PMID: 39673042
Background: Non-meningothelial intracranial mesenchymal tumors are a heterogeneous group of central nervous system neoplasms endowed with great variability clinically and histologically. For this precise reason, significant difficulties exist in specifically...
7.
Cepeda S, Romero R, Luque L, Garcia-Perez D, Blasco G, Luppino L, et al.
Neurooncol Adv . 2024 Dec; 6(1):vdae199. PMID: 39659831
Background: The pursuit of automated methods to assess the extent of resection (EOR) in glioblastomas is challenging, requiring precise measurement of residual tumor volume. Many algorithms focus on preoperative scans,...
8.
Bianconi A, Presta R, La Cava P, De Marco R, Zeppa P, Lacroce P, et al.
Neurosurg Rev . 2024 Oct; 47(1):823. PMID: 39453521
High-grade gliomas are the most prevalent neurooncological desease in adults, their incidence increases with age, peaking in the seventh decade. This paper aims to address how to select patients for...
9.
Armocida D, Bianconi A, Zancana G, Jiang T, Pesce A, Tartara F, et al.
J Neurooncol . 2024 Oct; 171(1):241-252. PMID: 39404938
Purpose: The goal of glioma surgery is maximal tumor resection associated with minimal post-operative morbidity. Diffusion tensor imaging-tractography/fiber tracking (DTI-FT) is a valuable white-matter (WM) visualization tool for diagnosis and...
10.
Satragno C, Schiavetti I, Cella E, Piciche F, Falcitano L, Resaz M, et al.
Clin Transl Radiat Oncol . 2024 Sep; 49:100849. PMID: 39318678
Background: High-grade glioma (HGG) patients post-radiotherapy often face challenges distinguishing true tumor progression (TTP) from pseudoprogression (PsP). This study evaluates the effectiveness of systemic inflammatory markers and volume of enhancing...